Renal Impairment Since monoclonal antibodies are not known to be eliminated via renal pathways, renal function is not expected to impact the pharmacokinetics of evolocumab
The complexity of the ERK/MAP-kinase pathway and the treatment of melanoma skin cancer
While the life expectancy of hypermobile EDS is usually normal, there are exceptions where more severe cases are accompanied by Chiari neurological malformations with cerebral spinal complications, colonic motility disorders with obstruction complications, collapsed lungs, poor wound healing and sepsis complications, severe bleeding disorders associated with EDS, cranial vertebral instability caused by trauma and other complications of other organ systems which can abbreviate life expectancy and cause significant morbidity to patients
7 In combination with existing prophylactic treatments, 38 GLP-1 RAs may represent a valuable option for the subset of obese patients, especially those who are refractory to first- and second-line treatments, expanding the therapeutic armamentarium available to the neurologists managing these complex cases
